Does Adding Pembro Improve PFS in High-Risk Cervical Cancer?

Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.
MDedge News

source https://www.medscape.com/s/viewarticle/997608?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost